Nicotine patch

MedicationExperimental0 reviews

—

Average score out of 5

Experimental — This treatment is under research. Available data is limited. Consult your doctor before making any decision.

A transdermal patch that delivers a continuous dose of nicotine. It is being investigated for Long COVID based on the hypothesis that it may displace the Spike protein from nicotinic receptors, thereby improving dysautonomia symptoms.

Information

Subcategory: nicotinic receptor agonist
Evidence level: 2/5
Evidence type: case series and ongoing clinical trials

Share your experience

Your feedback helps thousands of people find what really works.

Join the community